1. Patient-customized oligonucleotide therapy for a rare genetic disease;Kim;N Engl J Med,2019
2. The cost of getting personal;Nat Med,2019
3. Pace WD, Larson EB, Staton EW, the DEcIDE Methods Center N-of-1 Guidance Panel. Financing and economics of conducting N-of-1 trials. In: Kravitz RL, Duan N, eds, and the DEcIDE Methods Center N-of-1 Guidance Panel. Design and Implementation of N-of-1 Trials: A User’s Guide. Agency for Healthcare Research and Quality; 2014:23-32. Accessed November 10, 2022. https://effectivehealthcare.ahrq.gov/products/n-1-trials/research-2014-2
4. Gene-targeted therapies in pediatric neurology: challenges and opportunities in diagnosis and delivery;Shellhaas;Pediatr Neurol,2021
5. ‘N of 1’ therapies need a better model;Aartsma-Rus;Nat Med,2021